The Biology of Chronic Graft-Versus-Host Disease

  • H. J. Deeg
Part of the Experimental Hematology book series (HEMATOLOGY)


Chronic graft-versus-host (GVHD) disease occurs in as many as 30–50% of long-term survivors after allogeneic marrow transplantation, even when the donor was an HLA genotypically identical sibling (1, 2). Because of severe morbidity and mortality associated with this syndrome, it has a major effect on long-term results of clinical marrow transplantation (3). Chronic GVHD generally develops within 3 months to one year after transplantation. Three forms of onset have been recognized (4): 1) Progressive chronic GVHD, i.e. as a continuation of acute GVHD, 2) quiescent chronic GVHD, i.e. after a disease-free, asymptomatic interval following acute GVHD, and 3) de novo chronic GVHD in patients who never had any clinical manifestation of acute GVHD. The prognosis is the worst for patients with progressive chronic GVHD, intermediate with quiescent, and best with de novo chronic GVHD.


Aplastic Anemia Acute GVHD Chronic GVHD Autoimmune Hemolytic Anemia Marrow Graft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sullivan KM, Parkman R. The pathophysiology and treatment of graft-versus-host disease. In: Clinics in Haematology, 12: 775–789, 1983.Google Scholar
  2. 2.
    Deeg HJ, Storb R. Graft-versus-host disease: Pathophysiological and clinical aspects. Ann Rev Med 35: 11–24, 1984.PubMedCrossRefGoogle Scholar
  3. 3.
    Storb R, Prentice RL, Sullivan KM, et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 98: 461–466, 1983.PubMedCrossRefGoogle Scholar
  4. 4.
    Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57: 267–276, 1981.PubMedGoogle Scholar
  5. 5.
    Atkinson K, Farewell V, Storb R, et al. Analysis of late infections after human bone marrow transplantation: Role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 60: 714–720, 1982.PubMedGoogle Scholar
  6. 6.
    Graze PR, Gale RP. Chronic graft versus host disease: A syndrome of disordered immunity. Am J Med 66: 611–619, 1979.Google Scholar
  7. 7.
    Witherspoon RP, Lum LG, Storb R. Immunologic reconstitution after human marrow grafting. Semin Hematol 21: 2–10, 1984.PubMedGoogle Scholar
  8. 8.
    Tsoi M-S. Immunological mechanisms of graftversus-host disease in man. Transplantation 33: 459–464, 1982.PubMedCrossRefGoogle Scholar
  9. 9.
    The Pathology of Bone Marrow Transplantation, Sale GE, Shulman HM (eds). New York, Masson Publishing USA, Inc., 1984.Google Scholar
  10. 10.
    Storb R, Prentice RL, Hansen JA, et al. An association between HLA-B antigens and acute graftversus-host disease. Lancet 2: 816–819, 1983.PubMedCrossRefGoogle Scholar
  11. 11.
    Bross DS, Tutschka PJ, Farmer ER, et al. Predictive factors for acute graft-versus-host disease in patients transplanted with HLAidentical bone marrow. Blood 63: 1265–1270, 1984.PubMedGoogle Scholar
  12. 12.
    Storb R, Thomas ED. Allogeneic bone-marrow transplantation. Immunol Rev 71: 77–102, 1983.PubMedCrossRefGoogle Scholar
  13. 13.
    Atkinson K, Storb R, Ochs HD, et al. Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans. Transplantation 33: 168–173, 1982.PubMedCrossRefGoogle Scholar
  14. 14.
    Lonnqvist B, Ringden O, Wahren B, et al. Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation 38: 465–468, 1984.Google Scholar
  15. 15.
    Weiden PL, Sullivan KM, Flournoy MS, et al. Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304: 1529–1533, 1981.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • H. J. Deeg
    • 1
  1. 1.Fred Hutchinson Cancer Research Center and the University of Washington School of MedicineSeattleUSA

Personalised recommendations